DCXR and benign prostatic hyperplasia: For those 4 genes in BPH, only DCXR was cross-validated in two datasets (GSE132714: P-value <0.05; GSE7307: P-value <0.05), while ELAC2 was validated in GSE7307 (P-value <0.05) (Figure 2E).